#Health & Well-being # Biotherapies
- Oncology
- Dual therapy
- Glioblastoma
- Gold Nanoparticle
As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.
Discover >Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.
Discover >Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.
Discover >Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.
Discover >#Health & Well-being # Biotherapies
ORINOVA is developing a breakthrough innovation in oncology with a patented nanomedicine incorporating a unique dual therapy: a chemotherapy molecule combined with gold nanoparticles. This combination amplifies the effect of radiotherapy and optimizes tumor targeting, thus limiting side effects for patients. This intelligent nano-object could revolutionize the treatment of particularly resistant solid tumors, such as glioblastoma.
BACKGROUND
ORINOVA was founded in October 2024, building on more than 10 years of R&D in
Besançon. ORINOVA specializes in the development of nanospheres for oncology.
DESCRIPTION OF PRODUCTS / SERVICES / TECHNOLOGY
ORINOVA nanospheres contain gold nanoparticles and chemotherapy molecules, enabling dual therapy for the treatment of localized solid tumors such as glioblastoma or recurrent prostate cancer.
ACHIEVEMENTS / COLLABORATIONS / HIGHLIGHTS
A first in vivo POC demonstrated excellent results on glioblastoma. We collaborate with the University of BFC, via its 2 chrono environment and Right research laboratories.
COLLABORATIONS SOUGHT
.
1 patent
1 employee
STRENGHTS
Worldwide patent, POC in vivo excellent.
Patent team disruptive innovation
INNOVATION ASSETS
Dual therapy via nanosphere.
In the same field